These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26287812)

  • 1. Get real in individual participant data (IPD) meta-analysis: a review of the methodology.
    Debray TP; Moons KG; van Valkenhoef G; Efthimiou O; Hummel N; Groenwold RH; Reitsma JB;
    Res Synth Methods; 2015 Dec; 6(4):293-309. PubMed ID: 26287812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example.
    de Jong VMT; Moons KGM; Riley RD; Tudur Smith C; Marson AG; Eijkemans MJC; Debray TPA
    Res Synth Methods; 2020 Mar; 11(2):148-168. PubMed ID: 31759339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical approaches to identify subgroups in meta-analysis of individual participant data: a simulation study.
    Belias M; Rovers MM; Reitsma JB; Debray TPA; IntHout J
    BMC Med Res Methodol; 2019 Sep; 19(1):183. PubMed ID: 31477023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: Statistical recommendations for conduct and planning.
    Riley RD; Debray TPA; Fisher D; Hattle M; Marlin N; Hoogland J; Gueyffier F; Staessen JA; Wang J; Moons KGM; Reitsma JB; Ensor J
    Stat Med; 2020 Jul; 39(15):2115-2137. PubMed ID: 32350891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IPDmada: An R Shiny tool for analyzing and visualizing individual patient data meta-analyses of diagnostic test accuracy.
    Wang J; Keusters WR; Wen L; Leeflang MMG
    Res Synth Methods; 2021 Jan; 12(1):45-54. PubMed ID: 32808437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No consistent evidence of data availability bias existed in recent individual participant data meta-analyses: a meta-epidemiological study.
    Tsujimoto Y; Fujii T; Onishi A; Omae K; Luo Y; Imai H; Takahashi S; Itaya T; Pinson C; Nevitt SJ; Furukawa TA
    J Clin Epidemiol; 2020 Feb; 118():107-114.e5. PubMed ID: 31654789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials.
    Donegan S; Williamson P; D'Alessandro U; Garner P; Smith CT
    Stat Med; 2013 Mar; 32(6):914-30. PubMed ID: 22987606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ.
    Burke DL; Ensor J; Riley RD
    Stat Med; 2017 Feb; 36(5):855-875. PubMed ID: 27747915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study.
    Tierney JF; Fisher DJ; Burdett S; Stewart LA; Parmar MKB
    PLoS Med; 2020 Jan; 17(1):e1003019. PubMed ID: 32004320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual participant data meta-analyses compared with meta-analyses based on aggregate data.
    Tudur Smith C; Marcucci M; Nolan SJ; Iorio A; Sudell M; Riley R; Rovers MM; Williamson PR
    Cochrane Database Syst Rev; 2016 Sep; 9(9):MR000007. PubMed ID: 27595791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-stage random effects meta-analysis using linear mixed models for aggregate continuous outcome data.
    Papadimitropoulou K; Stijnen T; Dekkers OM; le Cessie S
    Res Synth Methods; 2019 Sep; 10(3):360-375. PubMed ID: 30523676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methodological quality of individual participant data meta-analysis on intervention effects: systematic review.
    Wang H; Chen Y; Lin Y; Abesig J; Wu IX; Tam W
    BMJ; 2021 Apr; 373():n736. PubMed ID: 33875446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative benefits of meta-analysis conducted with individual participant data versus aggregated data.
    Cooper H; Patall EA
    Psychol Methods; 2009 Jun; 14(2):165-76. PubMed ID: 19485627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis.
    Debray TP; Moons KG; Ahmed I; Koffijberg H; Riley RD
    Stat Med; 2013 Aug; 32(18):3158-80. PubMed ID: 23307585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRIME-IPD SERIES Part 1. The PRIME-IPD tool promoted verification and standardization of study datasets retrieved for IPD meta-analysis.
    Dewidar O; Riddle A; Ghogomu E; Hossain A; Arora P; Bhutta ZA; Black RE; Cousens S; Gaffey MF; Mathew C; Trawin J; Tugwell P; Welch V; Wells GA
    J Clin Epidemiol; 2021 Aug; 136():227-234. PubMed ID: 34044099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of continuous outcomes: Using pseudo IPD created from aggregate data to adjust for baseline imbalance and assess treatment-by-baseline modification.
    Papadimitropoulou K; Stijnen T; Riley RD; Dekkers OM; le Cessie S
    Res Synth Methods; 2020 Nov; 11(6):780-794. PubMed ID: 32643264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes.
    Smith CT; Williamson PR; Marson AG
    J Eval Clin Pract; 2005 Oct; 11(5):468-78. PubMed ID: 16164588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.